108 related articles for article (PubMed ID: 22262126)
1. Inhibition of STAT1 sensitizes renal cell carcinoma cells to radiotherapy and chemotherapy.
Zhu H; Wang Z; Xu Q; Zhang Y; Zhai Y; Bai J; Liu M; Hui Z; Xu N
Cancer Biol Ther; 2012 Apr; 13(6):401-7. PubMed ID: 22262126
[TBL] [Abstract][Full Text] [Related]
2. Zoledronic acid sensitizes renal cell carcinoma cells to radiation by downregulating STAT1.
Kijima T; Koga F; Fujii Y; Yoshida S; Tatokoro M; Kihara K
PLoS One; 2013; 8(5):e64615. PubMed ID: 23741352
[TBL] [Abstract][Full Text] [Related]
3. [Effects of SIPL1 screened by suppression subtractive hybridization (SSH) on biological function and drug resistance of renal cell carcinoma cells].
Li CY; Yao AM; Chang XN; Guo YH; Xu R
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):897-903. PubMed ID: 24506958
[TBL] [Abstract][Full Text] [Related]
4. Decitabine induces G2/M cell cycle arrest by suppressing p38/NF-κB signaling in human renal clear cell carcinoma.
Shang D; Han T; Xu X; Liu Y
Int J Clin Exp Pathol; 2015; 8(9):11140-8. PubMed ID: 26617834
[TBL] [Abstract][Full Text] [Related]
5. Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression.
Oguro T; Ishibashi K; Sugino T; Hashimoto K; Tomita S; Takahashi N; Yanagida T; Haga N; Aikawa K; Suzutani T; Yamaguchi O; Kojima Y
Eur J Cancer; 2013 May; 49(7):1715-24. PubMed ID: 23274199
[TBL] [Abstract][Full Text] [Related]
6. Radiosensitization by inhibiting STAT1 in renal cell carcinoma.
Hui Z; Tretiakova M; Zhang Z; Li Y; Wang X; Zhu JX; Gao Y; Mai W; Furge K; Qian CN; Amato R; Butler EB; Teh BT; Teh BS
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):288-95. PubMed ID: 19100922
[TBL] [Abstract][Full Text] [Related]
7. The expression of Cullin1 is increased in renal cell carcinoma and promotes cancer cell proliferation, migration, and invasion.
Ping JG; Wang F; Pu JX; Hou PF; Chen YS; Bai J; Zheng JN
Tumour Biol; 2016 Sep; 37(9):12823-12831. PubMed ID: 27449035
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of Human DAB2IP Gene Expression in Renal Cell Carcinoma Results in Resistance to Ionizing Radiation.
Yun EJ; Lin CJ; Dang A; Hernandez E; Guo J; Chen WM; Allison J; Kim N; Kapur P; Brugarolas J; Wu K; He D; Lai CH; Lin H; Saha D; Baek ST; Chen BPC; Hsieh JT
Clin Cancer Res; 2019 Jul; 25(14):4542-4551. PubMed ID: 31000589
[TBL] [Abstract][Full Text] [Related]
9. NUB1, an interferon-inducible protein, mediates anti-proliferative actions and apoptosis in renal cell carcinoma cells through cell-cycle regulation.
Hosono T; Tanaka T; Tanji K; Nakatani T; Kamitani T
Br J Cancer; 2010 Mar; 102(5):873-82. PubMed ID: 20160729
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of mitochondrial translation effectively sensitizes renal cell carcinoma to chemotherapy.
Wang B; Ao J; Yu D; Rao T; Ruan Y; Yao X
Biochem Biophys Res Commun; 2017 Aug; 490(3):767-773. PubMed ID: 28645610
[TBL] [Abstract][Full Text] [Related]
11. EIF3D promotes sunitinib resistance of renal cell carcinoma by interacting with GRP78 and inhibiting its degradation.
Huang H; Gao Y; Liu A; Yang X; Huang F; Xu L; Danfeng X; Chen L
EBioMedicine; 2019 Nov; 49():189-201. PubMed ID: 31669222
[TBL] [Abstract][Full Text] [Related]
12. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.
Li T; Cheng Y; Wang P; Wang W; Hu F; Mo X; Lv H; Xu T; Han W
J Exp Clin Cancer Res; 2015 Oct; 34():122. PubMed ID: 26474560
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation-regulated QPCT promotes sunitinib resistance by increasing HRAS stability in renal cell carcinoma.
Zhao T; Bao Y; Gan X; Wang J; Chen Q; Dai Z; Liu B; Wang A; Sun S; Yang F; Wang L
Theranostics; 2019; 9(21):6175-6190. PubMed ID: 31534544
[No Abstract] [Full Text] [Related]
14. STAT1-dependent expression of energy metabolic pathways links tumour growth and radioresistance to the Warburg effect.
Pitroda SP; Wakim BT; Sood RF; Beveridge MG; Beckett MA; MacDermed DM; Weichselbaum RR; Khodarev NN
BMC Med; 2009 Nov; 7():68. PubMed ID: 19891767
[TBL] [Abstract][Full Text] [Related]
15. PABPC1L Induces IDO1 to Promote Tryptophan Metabolism and Immune Suppression in Renal Cell Carcinoma.
Shu G; Chen M; Liao W; Fu L; Lin M; Gui C; Cen J; Lu J; Chen Z; Wei J; Chen W; Wang Y; Zhu J; Zhao T; Liu X; Jing J; Liu GC; Pan Y; Luo J; Zhang J
Cancer Res; 2024 May; 84(10):1659-1679. PubMed ID: 38382068
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of carbonic anhydrase IX (CA9) sensitizes renal cell carcinoma to ionizing radiation.
Duivenvoorden WC; Hopmans SN; Gallino D; Farrell T; Gerdes C; Glennie D; Lukka H; Pinthus JH
Oncol Rep; 2015 Oct; 34(4):1968-76. PubMed ID: 26252502
[TBL] [Abstract][Full Text] [Related]
17. Retinoblastoma protein in human renal cell carcinoma in relation to alterations in G1/S regulatory proteins.
Hedberg Y; Ljungberg B; Roos G; Landberg G
Int J Cancer; 2004 Mar; 109(2):189-93. PubMed ID: 14750168
[TBL] [Abstract][Full Text] [Related]
18. MDM-2 antagonists induce p53-dependent cell cycle arrest but not cell death in renal cancer cell lines.
Tsao CC; Corn PG
Cancer Biol Ther; 2010 Dec; 10(12):1315-25. PubMed ID: 20953142
[TBL] [Abstract][Full Text] [Related]
19. Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma.
Hirata H; Hinoda Y; Nakajima K; Kawamoto K; Kikuno N; Ueno K; Yamamura S; Zaman MS; Khatri G; Chen Y; Saini S; Majid S; Deng G; Ishii N; Dahiya R
Int J Cancer; 2011 Apr; 128(8):1793-803. PubMed ID: 20549706
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling.
Kojima T; Shimazui T; Hinotsu S; Joraku A; Oikawa T; Kawai K; Horie R; Suzuki H; Nagashima R; Yoshikawa K; Michiue T; Asashima M; Akaza H; Uchida K
Oncogene; 2009 Jan; 28(2):297-305. PubMed ID: 18931698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]